BILINSKY IGOR Insider Trades

Insider Trading History

Track insider trading activity for BILINSKY IGOR. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $2.16M 146,050 shares
Last Trade
Sep 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68k 7,813 shares
$8.70
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $695k 46,878 shares
Last Trade
Sep 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$68k 7,813 shares
$8.70
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $2.11M 142,074 shares
Last Trade
Sep 08, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$34.6k 3,976 shares
$8.70
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $2.11M 142,709 shares
Last Trade
Sep 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.8k 8,789 shares
$8.28
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $261k 17,580 shares
Last Trade
Sep 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.8k 8,789 shares
$8.28
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $2.05M 138,237 shares
Last Trade
Sep 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$37k 4,472 shares
$8.28
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $2.04M 137,896 shares
Last Trade
Jun 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.98M 133,920 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 3,976 shares
$4.23
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $811k 54,691 shares
Last Trade
Jun 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $391k 26,369 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.8k 8,790 shares
$3.96
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.93M 130,083 shares
Last Trade
Jun 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.7k 4,473 shares
$3.96
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.99M 134,556 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.8k 8,790 shares
$3.96
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.74M 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.86M 125,766 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$76.2k 16,628 shares
$4.58
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $926k 62,504 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $2.11M 142,394 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $521k 35,159 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.3k 8,790 shares
$3.79
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.3k 3,517 shares
$3.79
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.65M 111,148 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.2k 6,903 shares
$3.79
$14.82
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $1.75M 118,051 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$46.6k 12,307 shares
$3.79
$14.82

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up